je.st

Home › lilly

Tag: lilly

Barclays Boosts Eli Lilly and Price Target to $69.00

2015-01-17 07:52:30| Food - Topix.net

The firm currently has an "equal weight" rating on the stock. Barclays' price target would suggest a potential downside of 2.38% from the company's current price.

Tags: price target eli lilly

Barclays Boosts Eli Lilly and Price Target to $69.00

2015-01-17 05:21:54| Agriculture - Topix.net

The firm currently has an "equal weight" rating on the stock. Barclays' price target would suggest a potential downside of 2.38% from the company's current price.

Tags: price target eli lilly

Lilly sees insurers pushing harder for discounts

2015-01-14 10:37:21| Agriculture - Topix.net

Health-coverage managers are becoming more aggressive in demanding discounts and exclusive deals from drugmakers to drive down the cost of medicine, Eli Lilly and Co.'

Tags: discounts sees harder pushing

Lilly, Merck Enter Collaboration Agreement to Research Immuno-Oncology Combination Regimens in Multiple Types of Cancer

2015-01-13 14:00:00| Merck.com - Research & Development News

Dateline City: KENILWORTH, N.J. & INDIANAPOLIS Combinations of KEYTRUDA (pembrolizumab) with Alimta (pemetrexed), Cyramza (ramucirumab), or necitumumab to be explored KENILWORTH, N.J. & INDIANAPOLIS--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the US and Canada, and Eli Lilly and Company (NYSE:LLY) announced today an oncology clinical trial collaboration to evaluate the safety, tolerability and efficacy of KEYTRUDA (pembrolizumab), Mercks anti-PD-1 therapy, in combination with Lilly compounds in multiple clinical trials: Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558Claire Mulhearn, 908-236-1118orInvestors:Justin Holko, 908-740-1879orLillyEli Lilly and CompanyKeri McGrath, 317-277-3768Communications Managermcgrath_happeks@lilly.com Ticker Slug: Ticker: MRK Exchange: NYSE Ticker: LLY Exchange: NYSE read more

Tags: enter research agreement types